Cita APA

Veltkamp, R., Korompoki, E., Harvey, K., Harvey, E. R., Fießler, C., Malzahn, U., . . . Palà, E. (2025). Direct oral anticoagulants versus no anticoagulation for the prevention of stroke in survivors of intracerebral haemorrhage with atrial fibrillation (PRESTIGE-AF): A multicentre, open-label, randomised, phase 3 trial.

Citación estilo Chicago

Veltkamp, Roland, Eleni Korompoki, Kirsten Harvey, Emily R. Harvey, Cornelia Fießler, Uwe Malzahn, Joan Montaner, y Elena Palà. Direct Oral Anticoagulants Versus No Anticoagulation for the Prevention of Stroke in Survivors of Intracerebral Haemorrhage With Atrial Fibrillation (PRESTIGE-AF): A Multicentre, Open-label, Randomised, Phase 3 Trial. 2025.

Cita MLA

Veltkamp, Roland, et al. Direct Oral Anticoagulants Versus No Anticoagulation for the Prevention of Stroke in Survivors of Intracerebral Haemorrhage With Atrial Fibrillation (PRESTIGE-AF): A Multicentre, Open-label, Randomised, Phase 3 Trial. 2025.